Thank you for donating!

You can donate using the following services.


  1. 24.04.18

    CTD Holdings Closes $2.00 Million Private Placement

    "We are pleased to again conclude a financing with significant insider participation," said N. Scott Fine, CTD Chairman and CEO...

    Read more
  2. 11.04.18

    Dementia Strikes Children Too

    The Dementia Strikes Children Too campaign aims to raise awareness of childhood dementia, drive for better clinical education of this group of diseases, and put in place the systems and tools for earlier diagnosis...

    Read more
  3. 04.04.18

    CTD Holdings Conducts Initial Review of Safety Data for its Phase I and Phase I/II Trials of Trappsol® Cyclo™ to Treat Niemann-Pick Disease Type C

    CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of disease with unmet medical need, announced today that the company has completed an initial review of safety data for its ongoing trials...

    Read more
  4. 16.02.18

    IMPORTANT: The Data Protection Law is Changing!

    Due to changes in data protection legislation, soon NPUK won’t be able to contact you about any of our services or activities unless you explicitly give your consent.

    Read more
  5. 01.02.18

    NPUK News: Winter 2018 Issue

    The NPUK News Winter 2018 Issue is now available, featuring research and clinical trial updates, fundraising news, and much much more...

    Read more